What is personalised cancer medicine?
Learn about personalised medicine and precision medicine in cancer in this short video.
top of page
Norwegian Cancer Precision Medicine Implementation Consortium
Latest news
- Sep 5
- 2 min
GSK enters IMPRESS Norway
Two precision medicine drugs from CONNECT partner GSK are the newest additions to the clinical trial IMPRESS.
- Aug 21
- 3 min
Personalised medicine to relieve the health service
Smaller patient groups and targeted treatments are the future of cancer care in Norway.
- May 2
- 3 min
Advancing precision cancer medicine via European collaboration
Learn more about the EU-funded Norwegian initiatives PCM4EU and PRIME-ROSE, and the Norwegian MATRIX Centre. Two Norwegian EU-funded...
- Feb 28
- 3 min
Success criteria for industry-sponsored clinical trials
The third educational seminar in the clinical trials meeting series arranged by CONNECT Working Group 2 took place via Zoom on 13 February.
- Oct 31, 2022
- 5 min
CONNECT seminar: investigator-initiated clinical trials
How can researchers have successful collaborations with industry in clinical studies? This was a central question at a recent CONNECT semina
- Oct 18, 2022
- 1 min
Inclusion of clinical opinions in economic evaluations
How can clinicians be more involved in healthcare decision-making?
- Sep 26, 2022
- 4 min
Kicking off the Clinical Trials meeting series
Industry-sponsored clinical studies in Norway were in focus at the kick-off meeting for a new meeting series hosted by CONNECT Working Group
- Aug 31, 2022
- 4 min
The future of precision cancer medicine
The first national initiatives for precision cancer medicine have successfully taken shape in Norway, but what has been achieved and what do
bottom of page